Research Output per year
Personal profile
Experience
- Director, Division of Pulmonary Medicine, Taipei Medical University- Wan Fang Hospital
- Assistant Professor, Medicine, Faculty of Medicine, National Yang-Ming University
- 2008.08-2017.09 Instructor, School of Respiratory Therapy, Taipei Medical University
Education
- 2005-2008 M.S., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1986-1993 M.D., Faculty of Medicine, National Yang-Ming University
Fingerprint Dive into the research topics where Jer-Hwa Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Taiwan
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Chemoradiotherapy
Medicine & Life Sciences
Pneumonia
Medicine & Life Sciences
Tuberculosis
Medicine & Life Sciences
Thorax
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2004 2018
6
Citations
(Scopus)
Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses
Chang, J. H., Cheng, C. W., Yang, Y. C., Chen, W. S., Hung, W. Y., Chow, J. M., Chen, P. S., Hsiao, M., Lee, W. J. & Chien, M. H., Aug 22 2018, In : Journal of Experimental and Clinical Cancer Research. 37, 1, 199.Research output: Contribution to journal › Article
Dipeptidyl Peptidase 4
Apigenin
Gastropoda
Epidermal Growth Factor Receptor
Lung Neoplasms
1
Citation
(Scopus)
Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment
Yen, Y. C., Hsu, H. L., Chang, J. H., Lin, W. C., Chang, Y. C., Chang, C. L., Chow, J. M., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Jan 1 2018, (Accepted/In press) In : Radiotherapy and Oncology.Research output: Contribution to journal › Article
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Radiotherapy
Thorax
Therapeutics
1
Citation
(Scopus)
Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities
Hung, W. Y., Chang, J. H., Cheng, Y., Chen, C. K., Chen, J. Q., Hua, K. T., Cheng, C. W., Hsiao, M., Chung, C. L., Lee, W. J. & Chien, M. H., Jan 1 2018, In : Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 51, 1, p. 337-355 19 p.Research output: Contribution to journal › Article
Chemotactic Factors
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Leukocytes
Lewis Lung Carcinoma
8
Citations
(Scopus)
The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
Weng, M. S., Chang, J. H., Hung, W. Y., Yang, Y. C. & Chien, M. H., Mar 16 2018, In : Journal of Experimental and Clinical Cancer Research. 37, 1, 61.Research output: Contribution to journal › Review article
Epidermal Growth Factor Receptor
Drug Resistance
Reactive Oxygen Species
Neoplasms
NADPH Oxidase
2
Citations
(Scopus)
Association of time-serial changes in ambient particulate matters (PMs) with respiratory emergency cases in Taipei’s Wenshan District
Chang, J. H., Hsu, S. C., Bai, K. J., Huang, S. K. & Hsu, C. W., Jul 1 2017, In : PLoS One. 12, 7, e0181106.Research output: Contribution to journal › Article
Emergency rooms
Particulate Matter
asthma
Hospital Emergency Service
particulates